Suppr超能文献

[癌基因与喉癌。表皮生长因子受体、p21 原癌基因和人乳头瘤病毒 DNA 感染]

[Oncogenes and cancer of the larynx. EGFR, p21 ras and HPV-DNA infections].

作者信息

Almadori G, Cadoni G, Maurizi M, Ottaviani F, Paludetti G, Cattani P, Scambia G

机构信息

Istituti di Clinica Otorinolaringoiatrica, Università Cattolica del Sacro Cuore, Roma.

出版信息

Acta Otorhinolaryngol Ital. 1995 Feb;15(1 Suppl 46):1-22.

PMID:7793243
Abstract

The modern concept of oncogenesis is based upon the interaction between factors which modulate cellular growth and differentiation, in particular oncogenes and tumor suppressor genes. The molecular events which induce laryngeal carcinogenesis are not yet known. Protoncogenes seem to be the target of the risk factors (cigarette smoking, alcohol abuse, ionizing radiations and, not least HPV-DNA) that are commonly considered related to laryngeal squamous cell carcinoma. New information on the role of alterations of oncogenes and/or their proteic products in laryngeal cancer will be useful in identifying new diagnostic and clinical therapeutical applications. The Authors investigated Epidermal Growth Factor Receptor (EGFR) expression in 103 primary laryngeal squamous cell carcinoma and 42 normal laryngeal tissue specimens in order to assess its clinical significance in primary laryngeal cancer. Significantly higher EGFR levels were found in cancer specimens compared with normal mucosa (p < 0.001). EGFR expression did not correlate with age, tumor localization, T classification, cervicallymphonode involvement or surgery, whereas in G3 tumors it was significantly higher than in G1-G2 (p < 0.05). Follow-up data were available for 74 cases: EGFR levels resulted significantly higher in patients who had a recurrence of the disease than those in recurrence-free patients (p < 0.05). The 24-month disease-free survival (DFS) was 58% for EGFR+ patients and 82% for EGFR-subjects. Multivariate analysis permitted identification of EGFR status and tumor localization as significant independent prognostic factors. Data reported here suggest that EGFR expression probably plays a role not only by regulating the growth of laryngeal cancer, but also by identifying a sub-set of laryngeal cancer patients at a higher degree of relapse risk and with an unfavorable prognosis. Furthermore, in this study p21-ras expression in 43 primary laryngeal cancers and in 7 normal laryngeal mucosa specimens was evaluated. Scattered p21 levels, expressed as optical density (O.D), were found in normal mucosa (median = 1.94) and in primary laryngeal tumours (median = 1.74). Higher p21 levels were found in neoplastic tissue than in normal laryngeal tissue (median = 2.54 vs median = 1.94; p = 0.023). The correlation between p21 ras protein and EGFR levels was also investigated. EGFR+ cases do not show any difference in p21 expression with respect to EGFR- cases (median = 1.52 O.D. vs median = 1.84). Our findings suggest that overexpression of p21 is associated with malignant phenotype in laryngeal cancer.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

现代肿瘤发生学概念基于调节细胞生长和分化的因素之间的相互作用,特别是癌基因和肿瘤抑制基因。诱导喉癌发生的分子事件尚不清楚。原癌基因似乎是通常被认为与喉鳞状细胞癌相关的危险因素(吸烟、酗酒、电离辐射,尤其是人乳头瘤病毒DNA)的作用靶点。关于癌基因改变和/或其蛋白质产物在喉癌中的作用的新信息,将有助于确定新的诊断和临床治疗应用。作者研究了103例原发性喉鳞状细胞癌和42例正常喉组织标本中表皮生长因子受体(EGFR)的表达,以评估其在原发性喉癌中的临床意义。与正常黏膜相比,癌组织标本中EGFR水平显著更高(p<0.001)。EGFR表达与年龄、肿瘤定位、T分级、颈部淋巴结受累或手术无关,而在G3肿瘤中,其表达显著高于G1-G2肿瘤(p<0.05)。74例患者有随访数据:疾病复发患者的EGFR水平显著高于无复发患者(p<0.05)。EGFR阳性患者的24个月无病生存率(DFS)为58%,EGFR阴性患者为82%。多因素分析确定EGFR状态和肿瘤定位为显著的独立预后因素。此处报告的数据表明,EGFR表达可能不仅通过调节喉癌生长发挥作用,还通过识别复发风险较高且预后不良的一部分喉癌患者发挥作用。此外,在本研究中,评估了43例原发性喉癌和7例正常喉黏膜标本中p21-ras的表达。在正常黏膜(中位数=1.94)和原发性喉肿瘤(中位数=1.74)中发现了散在的p21水平,以光密度(O.D)表示。肿瘤组织中的p21水平高于正常喉组织(中位数=2.54对中位数=1.94;p=0.023)。还研究了p21 ras蛋白与EGFR水平之间的相关性。EGFR阳性病例与EGFR阴性病例在p21表达上无差异(中位数=1.52 O.D.对中位数=1.84)。我们的研究结果表明,p21的过表达与喉癌的恶性表型相关。(摘要截选至400字)

相似文献

3
Clinical and molecular prognostic factors in operable laryngeal cancer.可手术喉癌的临床及分子预后因素
Eur Arch Otorhinolaryngol. 2005 Nov;262(11):890-8. doi: 10.1007/s00405-005-0916-3. Epub 2005 Mar 1.

引用本文的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验